BIOMAT Database Logo BIOMAT Database Logo

The treatment of low-renin ("primary") hyperaldosteronism. 1978

J B Ferriss, and D G Beevers, and K Boddy, and J J Brown, and D L Davies, and R Fraser, and D Kremer, and A F Lever, and J I Robertson

UI MeSH Term Description Entries
D008297 Male Males
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000306 Adrenal Cortex Neoplasms Tumors or cancers of the ADRENAL CORTEX. Adrenocortical Cancer,Cancer of Adrenal Cortex,Adrenal Cortex Cancer,Cancer of the Adrenal Cortex,Neoplasms, Adrenal Cortex,Adrenal Cortex Cancers,Adrenal Cortex Neoplasm,Adrenocortical Cancers,Cancer, Adrenal Cortex,Cancer, Adrenocortical,Cancers, Adrenal Cortex,Cancers, Adrenocortical,Neoplasm, Adrenal Cortex

Related Publications

J B Ferriss, and D G Beevers, and K Boddy, and J J Brown, and D L Davies, and R Fraser, and D Kremer, and A F Lever, and J I Robertson
[Plasma renin activity in primary hyperaldosteronism].
October 1973, Orvosi hetilap,
J B Ferriss, and D G Beevers, and K Boddy, and J J Brown, and D L Davies, and R Fraser, and D Kremer, and A F Lever, and J I Robertson
Low-renin hypertension with hyperaldosteronism in childhood.
January 1980, Progress in biochemical pharmacology,
J B Ferriss, and D G Beevers, and K Boddy, and J J Brown, and D L Davies, and R Fraser, and D Kremer, and A F Lever, and J I Robertson
[Clinical and morphologic characteristics of low-renin hyperaldosteronism].
August 1987, Kardiologiia,
J B Ferriss, and D G Beevers, and K Boddy, and J J Brown, and D L Davies, and R Fraser, and D Kremer, and A F Lever, and J I Robertson
[Potassium and the concentrations of plasma renin during primary hyperaldosteronism].
May 1968, Pathologie et biologie,
J B Ferriss, and D G Beevers, and K Boddy, and J J Brown, and D L Davies, and R Fraser, and D Kremer, and A F Lever, and J I Robertson
Treatment of primary hyperaldosteronism.
October 2020, Medicina clinica,
J B Ferriss, and D G Beevers, and K Boddy, and J J Brown, and D L Davies, and R Fraser, and D Kremer, and A F Lever, and J I Robertson
[Treatment of primary hyperaldosteronism].
March 2004, Orvosi hetilap,
J B Ferriss, and D G Beevers, and K Boddy, and J J Brown, and D L Davies, and R Fraser, and D Kremer, and A F Lever, and J I Robertson
Circadian rhythm of plasma renin activity in primary hyperaldosteronism.
February 1976, The Journal of clinical endocrinology and metabolism,
J B Ferriss, and D G Beevers, and K Boddy, and J J Brown, and D L Davies, and R Fraser, and D Kremer, and A F Lever, and J I Robertson
[Surgical treatment of different forms of hyperaldosteronism with low renin activity in the blood plasma].
December 1980, Kardiologiia,
J B Ferriss, and D G Beevers, and K Boddy, and J J Brown, and D L Davies, and R Fraser, and D Kremer, and A F Lever, and J I Robertson
[Diagnostic importance of determination of renin activity in primary hyperaldosteronism].
July 1977, Klinicheskaia meditsina,
J B Ferriss, and D G Beevers, and K Boddy, and J J Brown, and D L Davies, and R Fraser, and D Kremer, and A F Lever, and J I Robertson
[Myocardial function and left ventricular hypertrophy in patients with primary hyperaldosteronism and low-renin hypertension].
August 1987, Kardiologiia,
Copied contents to your clipboard!